Home Current Issue Previous Issues Published Ahead-of-Print CME Collections For Authors Journal Info
Skip Navigation LinksHome > October 2004 - Volume 83 - Issue 10 > Botulinum Toxin for Lower Limb Spasticity in Children with C...
American Journal of Physical Medicine & Rehabilitation:
October 2004 - Volume 83 - Issue 10 - pp 766-773
Research Article: Spasticity

Botulinum Toxin for Lower Limb Spasticity in Children with Cerebral Palsy: A Single-Blinded Trial Comparing Dilution Techniques

Lee, Li-Rong MD; Chuang, Yao-Chia MD, MS; Yang, Baii-Jia MD; Hsu, Min-Jung MD; Liu, Ying-Hung MD

Collapse Box

Abstract

Lee LR, Chuang YC, Yang BJ, Hsu MJ, Liu YH: Botulinum toxin for lower limb spasticity in children with cerebral palsy: A single-blinded trial comparing dilution techniques. Am J Phys Med Rehabil 2004;83:766-773.

Objective: To compare the effect of equivalent doses of botulinum toxin type A given in high-volume or low-volume injections on lower limb spasticity in children with cerebral palsy.

Design: A total of 17 subjects whose modified Ashworth scale scores in the calf flexors bilaterally ranged from 2 to 3 were enrolled. The right gastrocnemius was injected with botulinum toxin type A using a high-volume preparation (100 IU/4 ml), and the left gastrocnemius was injected with a low-volume preparation (100 IU/1 ml). The amplitude and area of the compound muscle action potential for both medial gastrocnemius muscles, the dynamic muscle range, static muscle range, modified Ashworth scale for both ankles, and the Gross Motor Functional Classification System were assessed before and after treatment.

Results: Spasticity was reduced in both legs. There was no significant difference in the changes in the amplitude and area of compound muscle action potential (P = 0.74 and 0.30, respectively), dynamic muscle range (P = 0.7), static muscle range (P = 0.65), and modified Ashworth scale (P = 1) in the right vs. left legs after botulinum toxin type A injection. The high-volume preparation did not cause more pain.

Conclusions: A higher volume preparation with a 4-fold dilution of botulinum toxin type A does not yield better results than a low-volume preparation.

© 2004 Lippincott Williams & Wilkins, Inc.

You currently do not have access to this article.

You may need to:

Note: If your society membership provides for full-access to this article, you may need to login on your society’s web site first.

Article Tools

You currently do not have access to this article.

You may need to:

Note: If your society membership provides for full-access to this article, you may need to login on your society’s web site first.

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.